When do you consider re-starting treatment for a patient with relapsed myeloma?
For example, how significant does the M protein have to increase for you to begin a conversation about new therapy?
1 Answer
Mednet MemberInvited Expert
Medical Oncology · Winship Cancer Institute of Emory University
Answered on
Do you start anti-myeloma therapy when patients have progressive disease (25% increase in paraprotein or new or worsening myeloma bone disease) or clinical relapse (CRAB criteria, hyperviscosity, new plasmacytoma)? The goal is to pull the trigger right before clinical relapse.
How is this done in th...
Join for free or sign in to see the full answer